icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Where’s Walmart? Opening of Canadian CBD Market Prompts Speculation About Retail Giant

By William Sumner, Hemp Business Journal Contributor Last month, rumors emerged that Walmart’s Canada division was conducting preliminary investigations into stocking its stores with CBD products, a move many consider to be inspired by Canada’s legalizing adult-use cannabis sales. Though details are not forthcoming, the very rumor of Walmart’s making moves into the CBD market […]
Read more

Investors Waking Up to Hemp as Cannabis Stocks Retrace

By Sean Murphy, Director of Hemp Analytics, New Frontier Data Investors are waking up to the hemp industry. Hemp is proving its opportunity for financial returns, and potential for social and environmental impact. While the first five years of the cannabis stock “green rush” was dominated by retail over-the-counter (OTC) traders, family offices and high […]
Read more

Differing State Hemp Regulations, Fees, Present Knotty Choices for Cultivators

By J.J. McCoy, Senior Managing Editor, New Frontier Data Not that the expanding patchwork of licensing regulations for hemp programs throughout the United States can be confusing and uneven, but had Johnny Appleseed faced all the challenges now confronting prospective American cultivators, he might have just stayed home. Make no mistake: Industrial hemp represents booming business, […]
Read more

Canada Goes Fully Legal

By Yona Torres Editor New Frontier Data All eyes are on Canada as the country takes its first few steps into a fully legal cannabis landscape. As such, Canada is taking a measured pace in its rollout of legal adult-use cannabis. The country is currently limiting its product offerings and will not permit edibles. “We […]
Read more

Mile High Labs Funding Round Underscores Contrasts in Cannabis Wholesaling

By J.J. McCoy, Senior Managing Editor, New Frontier Data Mile High Labs caught attention last week with the company’s announcement of a $35 million raise in what was described as the “largest Series A financing in the cannabis market history.” It was a newsworthy claim for the Colorado cannabis extraction company, and demonstrated its commitment toward […]
Read more

New York State Holds ‘Listening Sessions’ on Cannabis Legalization

By Noah Potter, Of Counsel to Hoban Law Group Last month, New York State Governor Andrew Cuomo’s office announced a series of 15 listening sessions about cannabis legalization (including one in Manhattan last week) to hear public comment through October. Cuomo’s new approach contrasts with the process that resulted in enactment of the Compassionate Care […]
Read more

Examining the Oceania Cannabis Market

By Yona Torres Editor New Frontier Data  New Frontier Data’s most recent report release is an analysis of the budding cannabis market in Oceania (Australia, New Zealand, and the islands that comprise Melanesia, Micronesia, and Polynesia.) As the legal cannabis industry expands globally, Oceania serves as another example of significant and economically developed countries, including Australia, [...]
Read more
US hemp based sales

Passage of Legalization Puts California Out Front for Hemp

By William Sumner, Hemp Business Journal Contributor A victory for the legal hemp industry was struck late last month as California Governor Jerry Brown signed into law SB 1409, to legalize hemp farming in the state. Included in the law are a series of provisions to clarify and resolve various conflicts between state laws and […]
Read more

DEA’s Rescheduling of CBD Is No Industry Cure-All

By J.J. McCoy, Senior Managing Editor, for New Frontier Data Recent news that the U.S. Drug Enforcement Agency (DEA) is rescheduling cannabidiol (CBD) for use in FDA-approved medicine was warmly welcomed by the cannabis industry, but it felt confusingly tepid on delivery. Overall, the announcement is a boon for Big Pharma companies looking to develop and […]
Read more

Hemp Stocks: A Look at Leading Public Hemp Companies

By William Sumner, Hemp Business Journal Contributor Last week, the hemp industry was abuzz with the news that the United States Drug Enforcement Administration (DEA) would move Epidiolex, a CBD-based drug derived from cannabis, from a Schedule I substance to a Schedule V substance. The scheduling does not explicitly pertain to CBD, but it does […]
Read more
Top